Serveur d'exploration sur les pandémies grippales

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Guillain-barré syndrome following influenza vaccination: causal or coincidental?

Identifieur interne : 000F71 ( PubMed/Checkpoint ); précédent : 000F70; suivant : 000F72

Guillain-barré syndrome following influenza vaccination: causal or coincidental?

Auteurs : James J. Sejvar ; Dina Pfeifer ; Lawrence B. Schonberger

Source :

RBID : pubmed:21681501

Abstract

In 1976, the emergence of a new swine-origin influenza virus prompted concerns about an impending influenza pandemic. Although the outbreak never materialized, the epidemiological link between Guillain-Barre syndrome, a potentially severe peripheral nerve disorder, and the influenza vaccines developed against this virus caught public health officials, clinicians, and the public by surprise. Subsequently, a great deal of scrutiny has been placed on the possible risk of other formulations of influenza vaccine causing this adverse event. Several epidemiologic and biological assessments have been performed in subsequent years to assess this risk, yet considerable uncertainty remains among health care providers about the possible association. The development and rapid implementation of vaccines against the pandemic 2009 A(H1N1) influenza virus once again highlighted this issue. This article reviews the evidence for and against the association of the 1976 influenza vaccines and subsequent seasonal influenza vaccines with the development of Guillain-Barré syndrome.

DOI: 10.1007/s11908-011-0194-8
PubMed: 21681501


Affiliations:


Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:21681501

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Guillain-barré syndrome following influenza vaccination: causal or coincidental?</title>
<author>
<name sortKey="Sejvar, James J" sort="Sejvar, James J" uniqKey="Sejvar J" first="James J" last="Sejvar">James J. Sejvar</name>
<affiliation>
<nlm:affiliation>Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road, Mailstop A-39, Atlanta, GA, 30333, USA, zea3@cdc.gov.</nlm:affiliation>
<wicri:noCountry code="subField">zea3@cdc.gov.</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Pfeifer, Dina" sort="Pfeifer, Dina" uniqKey="Pfeifer D" first="Dina" last="Pfeifer">Dina Pfeifer</name>
</author>
<author>
<name sortKey="Schonberger, Lawrence B" sort="Schonberger, Lawrence B" uniqKey="Schonberger L" first="Lawrence B" last="Schonberger">Lawrence B. Schonberger</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2011">2011</date>
<idno type="RBID">pubmed:21681501</idno>
<idno type="pmid">21681501</idno>
<idno type="doi">10.1007/s11908-011-0194-8</idno>
<idno type="wicri:Area/PubMed/Corpus">000F88</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000F88</idno>
<idno type="wicri:Area/PubMed/Curation">000F88</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000F88</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000F71</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000F71</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Guillain-barré syndrome following influenza vaccination: causal or coincidental?</title>
<author>
<name sortKey="Sejvar, James J" sort="Sejvar, James J" uniqKey="Sejvar J" first="James J" last="Sejvar">James J. Sejvar</name>
<affiliation>
<nlm:affiliation>Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road, Mailstop A-39, Atlanta, GA, 30333, USA, zea3@cdc.gov.</nlm:affiliation>
<wicri:noCountry code="subField">zea3@cdc.gov.</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Pfeifer, Dina" sort="Pfeifer, Dina" uniqKey="Pfeifer D" first="Dina" last="Pfeifer">Dina Pfeifer</name>
</author>
<author>
<name sortKey="Schonberger, Lawrence B" sort="Schonberger, Lawrence B" uniqKey="Schonberger L" first="Lawrence B" last="Schonberger">Lawrence B. Schonberger</name>
</author>
</analytic>
<series>
<title level="j">Current infectious disease reports</title>
<idno type="eISSN">1534-3146</idno>
<imprint>
<date when="2011" type="published">2011</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">In 1976, the emergence of a new swine-origin influenza virus prompted concerns about an impending influenza pandemic. Although the outbreak never materialized, the epidemiological link between Guillain-Barre syndrome, a potentially severe peripheral nerve disorder, and the influenza vaccines developed against this virus caught public health officials, clinicians, and the public by surprise. Subsequently, a great deal of scrutiny has been placed on the possible risk of other formulations of influenza vaccine causing this adverse event. Several epidemiologic and biological assessments have been performed in subsequent years to assess this risk, yet considerable uncertainty remains among health care providers about the possible association. The development and rapid implementation of vaccines against the pandemic 2009 A(H1N1) influenza virus once again highlighted this issue. This article reviews the evidence for and against the association of the 1976 influenza vaccines and subsequent seasonal influenza vaccines with the development of Guillain-Barré syndrome.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
<PMID Version="1">21681501</PMID>
<DateCompleted>
<Year>2011</Year>
<Month>11</Month>
<Day>10</Day>
</DateCompleted>
<DateRevised>
<Year>2020</Year>
<Month>03</Month>
<Day>06</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1534-3146</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>13</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2011</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Current infectious disease reports</Title>
<ISOAbbreviation>Curr Infect Dis Rep</ISOAbbreviation>
</Journal>
<ArticleTitle>Guillain-barré syndrome following influenza vaccination: causal or coincidental?</ArticleTitle>
<Pagination>
<MedlinePgn>387-98</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1007/s11908-011-0194-8</ELocationID>
<Abstract>
<AbstractText>In 1976, the emergence of a new swine-origin influenza virus prompted concerns about an impending influenza pandemic. Although the outbreak never materialized, the epidemiological link between Guillain-Barre syndrome, a potentially severe peripheral nerve disorder, and the influenza vaccines developed against this virus caught public health officials, clinicians, and the public by surprise. Subsequently, a great deal of scrutiny has been placed on the possible risk of other formulations of influenza vaccine causing this adverse event. Several epidemiologic and biological assessments have been performed in subsequent years to assess this risk, yet considerable uncertainty remains among health care providers about the possible association. The development and rapid implementation of vaccines against the pandemic 2009 A(H1N1) influenza virus once again highlighted this issue. This article reviews the evidence for and against the association of the 1976 influenza vaccines and subsequent seasonal influenza vaccines with the development of Guillain-Barré syndrome.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Sejvar</LastName>
<ForeName>James J</ForeName>
<Initials>JJ</Initials>
<AffiliationInfo>
<Affiliation>Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road, Mailstop A-39, Atlanta, GA, 30333, USA, zea3@cdc.gov.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Pfeifer</LastName>
<ForeName>Dina</ForeName>
<Initials>D</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Schonberger</LastName>
<ForeName>Lawrence B</ForeName>
<Initials>LB</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Curr Infect Dis Rep</MedlineTA>
<NlmUniqueID>100888983</NlmUniqueID>
<ISSNLinking>1523-3847</ISSNLinking>
</MedlineJournalInfo>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="entrez">
<Year>2011</Year>
<Month>6</Month>
<Day>18</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2011</Year>
<Month>6</Month>
<Day>18</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2011</Year>
<Month>6</Month>
<Day>18</Day>
<Hour>6</Hour>
<Minute>1</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">21681501</ArticleId>
<ArticleId IdType="doi">10.1007/s11908-011-0194-8</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>JAMA. 1982 Aug 13;248(6):698-700</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7097920</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>JAMA. 1982 Jan 22-29;247(4):495</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">6172604</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Neurology. 1984 Feb;34(2):240-2</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">6538019</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Vaccine. 2000 Jul 1;18(26):2963-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10825597</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Epidemiol. 1984 Jun;119(6):880-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">6731430</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J R Soc Med. 1979 Sep;72(9):660-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">552571</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Epidemiol. 1991 May 1;133(9):952-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">2028981</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Neurology. 1988 Mar;38(3):375-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">2450302</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Arch Intern Med. 2006 Nov 13;166(20):2217-21</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17101939</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>JAMA. 2004 Nov 24;292(20):2478-81</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15562126</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 1998 Dec 17;339(25):1845-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9854122</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 1998 Dec 17;339(25):1797-802</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9854114</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Arch Neurol. 1982 Jan;39(1):21-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7055443</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Pa Med. 1978 Apr;81(4):47-8, 50-2</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">634621</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Neurology. 1987 Apr;37(4):550-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">2436091</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Neurology. 1987 Apr;37(4):685-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">3561781</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Emerg Infect Dis. 2006 Jan;12(1):29-33</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16494713</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Arch Neurol. 1985 Nov;42(11):1089-90</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">2996473</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Epidemiol. 2009 Feb 1;169(3):382-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19033158</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Ann Neurol. 1999 May;45(5):595-600</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10319881</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Prev Med. 2010 Oct;39(4):296-304</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20837279</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Infect Immun. 1983 Nov;42(2):824-30</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">6642653</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Epidemiol. 1979 Aug;110(2):105-23</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">463869</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Ann Neurol. 1982 Aug;12(2):119-28</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">6751212</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>JAMA. 1980 Jun 27;243(24):2490-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">6247520</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Neurol Sci. 1999 Apr 1;164(2):134-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10402024</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 1981 Jun 25;304(26):1557-61</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7231501</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect Dis. 2008 Jul 15;198(2):226-33</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18522505</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 1987 Feb 12;316(7):369-74</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">2433582</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 2005 Nov 5;366(9497):1653-66</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16271648</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Epidemiol. 1984 Jun;119(6):841-79</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">6328974</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Peripher Nerv Syst. 2005 Jun;10(2):94-112</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15958123</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations>
<list></list>
<tree>
<noCountry>
<name sortKey="Pfeifer, Dina" sort="Pfeifer, Dina" uniqKey="Pfeifer D" first="Dina" last="Pfeifer">Dina Pfeifer</name>
<name sortKey="Schonberger, Lawrence B" sort="Schonberger, Lawrence B" uniqKey="Schonberger L" first="Lawrence B" last="Schonberger">Lawrence B. Schonberger</name>
<name sortKey="Sejvar, James J" sort="Sejvar, James J" uniqKey="Sejvar J" first="James J" last="Sejvar">James J. Sejvar</name>
</noCountry>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/PandemieGrippaleV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000F71 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 000F71 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    PandemieGrippaleV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    RBID
   |clé=     pubmed:21681501
   |texte=   Guillain-barré syndrome following influenza vaccination: causal or coincidental?
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i   -Sk "pubmed:21681501" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd   \
       | NlmPubMed2Wicri -a PandemieGrippaleV1 

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Wed Jun 10 11:04:28 2020. Site generation: Sun Mar 28 09:10:28 2021